Drug Delivery Devices Market Size, Industry Outlook 2026-2035
According to Payal Rabde, who specializes in devices designed to administer medications safely, accurately, and efficiently through various routes of delivery, biologics, vaccines, insulin, oncology drugs, and other specialty therapeutics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the drug delivery devices market. The global drug delivery devices market size was estimated at USD 463.86 billion in 2025 and is predicted to increase from USD 500.23 billion in 2026 to approximately USD 986.7 billion by 2035, expanding at a CAGR of 7.84% from 2026 to 2035. Her analysis highlights the increasing adoption of wearable drug delivery devices for continuous and self-administered therapies, needle-free drug delivery systems to improve patient comfort and compliance, growing use of smart connected injectors with dose-tracking and remote monitoring capabilities, and growing demand for home-based drug delivery solutions and personalized treatment approaches. The research also examines the competitive strategies of key industry participants, including Stryker Corporation, Olympus Corporation, Richard Wolf GmbH, Misonix Inc., Integra LifeSciences Corporation, and Medtronic plc, shaping the future by enabling personalized and patient-centric therapies through wearable drug delivery technologies, integrating AI and digital health platforms to optimize medication adherence and dosing accuracy, and accelerating the adoption of next-generation biologics delivery systems for chronic disease management and specialty therapeutics in the global drug delivery devices market.
Last Updated : 24 July 2026
Category: Medical Devices
Insight Code: 6609
Format: PDF / PPT / Excel